Literature DB >> 6723385

Two-dimensional echocardiographic guiding of endomyocardial biopsy.

L Piérard, D El Allaf, V D'Orio, J C Demoulin, J Carlier.   

Abstract

Two-dimensional echocardiography provides adequate spatial orientation and anatomic definition. Eighteen consecutive patients undergoing myocardial biopsy had concomitant two-dimensional echocardiography during 22 biopsies of five to six samples each. The transducer was placed at the apex and in the subcostal area and four-chamber views were used. The bioptome was seen entering the right atrium and crossing the tricuspid valve to the right ventricle. The catheter was then manipulated under two-dimensional echocardiography and the tip's position was strictly adapted, using two different classic views before sampling. The success rate in visualizing the forceps and in defining the site of sampling was 100 percent, and no complication was noted. Radiation exposure was largely reduced. Two-dimensional echocardiography to guide endomyocardial biopsy may reduce the risk of perforation by a better anatomic definition of the sampling site. It permits sampling from different ventricular sites or from the same site during serial procedures for monitoring evolution or treatment.

Entities:  

Mesh:

Year:  1984        PMID: 6723385     DOI: 10.1378/chest.85.6.759

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

Review 1.  Echocardiographic guidance for diagnostic and therapeutic percutaneous procedures.

Authors:  Cam Tu Nguyen; Eunice Lee; Huai Luo; Robert J Siegel
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

2.  Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures.

Authors:  Se Yong Jang; Yongkeun Cho; Joon Hyuck Song; Sang Soo Cheon; Sun Hee Park; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Shung Chull Chae
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.